Insider Trading Activity - DIEKMAN JOHN D

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for DIEKMAN JOHN D

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2024-03-13 Purchase	2024-03-15 4:15 pm	Skye Bioscience Inc.	SKYE	5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner	450,000	$10	$4,500,000	10,179,505 (Indirect)	View
2024-01-31 Purchase	2024-02-02 4:32 pm	Skye Bioscience Inc.	SKYE	5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner	5,206,074	$2.31	$12,026,031	9,729,505 (Indirect)	View
2023-04-10 Sale	2023-04-12 4:51 pm	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	16,544,113	$0.12	$1,985,294	200,000 (Indirect)	View
2022-11-11 Sale	2022-11-15 8:32 pm	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	105,281	$2.7381	$288,267	3,907,624 (Indirect)	View
2022-10-31 Sale	2022-11-02 7:49 pm	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	54,209	$2.7688	$150,096	3,911,835 (Indirect)	View
2022-10-06 Sale	2022-10-11 7:10 pm	scPharmaceuticals Inc.	SCPH	5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	600,000	$4.1482	$2,488,907	410,268 (Indirect)	View
2022-09-14 Sale	2022-09-16 6:03 pm	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	558,168	$1.8764	$1,047,322	3,914,004 (Indirect)	View
2022-09-06 Sale	2022-09-08 8:01 pm	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	770,000	$2.0543	$1,581,835	3,936,331 (Indirect)	View
2022-09-06 Sale	2022-09-08 7:58 pm	scPharmaceuticals Inc.	SCPH	5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	226,622	$4.8405	$1,096,953	503,112 (Indirect)	View
2022-08-16 Sale	2022-08-18 8:05 pm	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	400,000	$1.6501	$660,060	3,967,131 (Indirect)	View
2022-04-11 Sale	2022-04-13 4:51 pm	scPharmaceuticals Inc.	SCPH	5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	270,000	$5	$1,350,000	537,301 (Indirect)	View
2022-02-04 Sale	2022-02-07 5:22 pm	Zai Lab Ltd	ZLAB	DIEKMAN JOHN D Director	1,000	$50.17	$50,170	67,615 (Direct)	View
2021-11-05 Sale	2021-11-08 4:23 pm	Zai Lab Ltd	ZLAB	DIEKMAN JOHN D Director	1,000	$91.65	$91,650	60,852 (Direct)	View
2021-08-05 Sale	2021-08-05 6:57 pm	Zai Lab Ltd	ZLAB	DIEKMAN JOHN D Director	1,000	$149.5	$149,500	61,852 (Direct)	View
2021-05-05 Sale	2021-05-06 7:49 pm	Zai Lab Ltd	ZLAB	DIEKMAN JOHN D Director	1,000	$153.62	$153,620	62,852 (Direct)	View
2020-12-22 Sale	2020-12-28 9:35 pm	Homology Medicines Inc.	FIXX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	500,000	$12.82	$6,410,000	181,435 (Indirect)	View
2020-12-14 Sale	2020-12-16 7:15 pm	Homology Medicines Inc.	FIXX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	500,000	$12.25	$6,125,915	201,435 (Indirect)	View
2020-11-11 Sale	2020-11-13 8:53 pm	IDEAYA Biosciences Inc.	IDYA	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. ROCKLAGE SCOTT M Former 10% holder 10% Owner	800,000	$13.66	$10,928,000	384,496 (Indirect)	View
2020-10-05 Sale	2020-10-07 9:30 pm	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. PARMAR KUSH ROCKLAGE SCOTT M Former 10% holder	175,000	$25.3	$4,427,500	2,037,654 (Indirect)	View
2020-06-16 Sale	2020-06-18 7:22 pm	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC PARMAR KUSH 10% Owner	140,000	$33.3	$4,662,000	313,497 (Indirect)	View
2020-06-11 Sale	2020-06-15 9:12 pm	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC PARMAR KUSH 10% Owner	245,000	$28.75	$7,044,412	414,105 (Indirect)	View
2020-05-19 Sale	2020-05-21 9:31 pm	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC PARMAR KUSH 10% Owner	255,000	$35.15	$8,963,250	423,905 (Indirect)	View
2019-10-07 Purchase	2019-10-09 6:23 pm	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. PARMAR KUSH 10% Owner	333,333	$15	$4,999,995	333,333 (Indirect)	View
2019-06-27 Sale	2019-07-01 8:01 pm	ARVINAS INC.	ARVN	5AM VENTURES III L.P. 5AM Partners III LLC 5AM Co-Investors III L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	810,000	$21.87	$17,714,700	91,162 (Indirect)	View
2019-06-21 Sale	2019-06-25 7:03 pm	Crinetics Pharmaceuticals Inc.	CRNX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. Former 10% holder	250,000	$22.2	$5,550,000	94,489 (Indirect)	View
2019-06-07 Sale	2019-06-11 09:58 am	ARVINAS INC.	ARVN	5AM VENTURES III L.P. 5AM Partners III LLC 5AM Co-Investors III L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	190,000	$19.65	$3,733,500	111,513 (Indirect)	View
2019-05-28 Purchase	2019-05-28 9:14 pm	IDEAYA Biosciences Inc.	IDYA	DIEKMAN JOHN D Director	250,000	$10	$2,500,000	118,521 (Indirect)	View
2019-05-16 Sale	2019-05-20 4:26 pm	Homology Medicines Inc.	FIXX	5AM Ventures IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 5AM Co-Investors IV L.P. 10% Owner	615,000	$21.47	$13,204,050	221,435 (Indirect)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
Ownership	2023-08-28 4:18 pm	N/A N/A	Skye Bioscience Inc.	SKYE	5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner	0	$0	1,557,205,277 (Indirect)	View
2023-06-29 Option Award	2023-06-30 4:13 pm	N/A N/A	Zai Lab Ltd	ZLAB	DIEKMAN JOHN D Director	18,903	$26.45	86,518 (Direct)	View
2021-06-16 Ownership	2022-02-14 4:06 pm	N/A N/A	Zai Lab Ltd	ZLAB	DIEKMAN JOHN D Director	3,515	$142.25	42,019 (Direct)	View
2021-03-04 Ownership	2022-02-14 4:06 pm	N/A N/A	Zai Lab Ltd	ZLAB	DIEKMAN JOHN D Director	15,318	$0	42,019 (Direct)	View
2022-01-03 Option Award	2022-01-04 9:08 pm	N/A N/A	Zai Lab Ltd	ZLAB	DIEKMAN JOHN D Director	7,763	$0	68,615 (Direct)	View
Ownership	2021-12-13 4:26 pm	N/A N/A	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M 10% Owner	0	$0	18,631,771 (Indirect)	View
2021-01-15 Option Award	2021-01-20 6:35 pm	N/A N/A	Zai Lab Ltd	ZLAB	DIEKMAN JOHN D Director	3,852	$0	63,852 (Direct)	View
Ownership	2021-01-04 07:34 am	N/A N/A	Zai Lab Ltd	ZLAB	DIEKMAN JOHN D Director	0	$0	60,000 (Direct)	View
2019-09-24 Option Award	2019-12-19 7:08 pm	N/A 2029-09-23	IDEAYA Biosciences Inc.	IDYA	DIEKMAN JOHN D Director	11,000	$0	11,000 (Direct)	View
2019-10-07 Conversion	2019-10-09 6:23 pm	N/A N/A	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. PARMAR KUSH 10% Owner	2,506,650	$0	333,333 (Indirect)	View
Ownership	2019-10-02 7:31 pm	N/A N/A	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D Schwab Andrew J. 10% Owner	0	$0	2,519,320 (Indirect)	View
2019-09-16 Other	2019-09-18 9:32 pm	N/A N/A	ARVINAS INC.	ARVN	5AM VENTURES III L.P. 5AM Partners III LLC 5AM Co-Investors III L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	562,017	$0	588,638 (Indirect)	View
2019-05-28 Conversion	2019-05-28 9:14 pm	N/A N/A	IDEAYA Biosciences Inc.	IDYA	DIEKMAN JOHN D Director	2,396,191	$0	118,521 (Indirect)	View
Ownership	2019-05-22 9:56 pm	N/A N/A	IDEAYA Biosciences Inc.	IDYA	DIEKMAN JOHN D Director	0	$0	2,713,066 (Indirect)	View

Insider Trading & Ownership - DIEKMAN JOHN D